drugset / Trial / NCT00667576
Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to investigate the initial dose and dose adjustment range for paricalcitol injection in patients with chronic kidney disease on hemodialysis who have secondary hyperparathyroidism.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paricalcitol | Other / unclassified | 2 ug | Intravenous |
| Subject | Paricalcitol | Other / unclassified | 4 ug | Intravenous |
| Subject | maxacalcitol | Small molecule | 5 ug | Intravenous |
| Subject | maxacalcitol | Small molecule | 10 ug | Intravenous |